SecBot SecBot

LIVN

LivaNova PLC
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. X0· CIK 0001639691 Healthcare & Medical Devices
$92.44 +1.12 (+1.23%)
Nov 16 4:00 PM ET · prev $91.32
Market cap
$5.0B
Mid cap
Consensus
Buy
81% Buy or better · 16 analysts
Median target
$110.00
+19% · range $75.00–120.00
1 year
+72.3%
from $53.64 · Nov 17
30 days
+18.3%
from $78.14
52-week range
$53.42–94.19
−2% from high · low Nov 20
Avg volume 20D
783.4K
Nov 4 spike 3.79M
Short interest
6.36M
≈11.6% of shares · +2.6%
Days to cover
12.4
at average volume
Insider net
−$1.3M
0 buyers · 4 sellers · since Mar 30
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
10
analyzed by SecBot
SecBot read BULLISH 6 reports · 90 days
Balance 0 bearish · 1 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 6/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders sold $1.3M.

  • InstitutionsBULLISH

    Q3 2026: 21 added (0 new), 12 trimmed or exited.

  • AnalystsBULLISH

    13 of 16 rate it Buy or better. Median target $110.00 (+19%).

  • Short sellersSTEADY

    Short interest +2.6% to 6.36M shares. 12.4 days to cover, ≈11.6% of shares.

  • TrendUPTREND

    15% above its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
FMR LLCADD3,976,650$304.2M
Invesco Ltd.ADD2,914,016$222.9M
UBS Group AGADD536,936$41.1M
BARCLAYS PLCADD289,169$22.1M
PRINCIPAL FINANCIAL GROUP INCADD252,352$19.3M
HRT FINANCIAL LPDOUBLED191,385$14.6M
Squarepoint Ops LLCDOUBLED130,806$10.0M
Verition Fund Management LLCDOUBLED126,393$9.7M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

16 analysts
Buy 81% rate it Buy or better
Strong Buy6Buy7Hold3Sell0Strong Sell0
12-month targets · 11 analysts

Price is inside the target range. Median implies +19%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 9, 2026Barclays
MAINTAIN
MAINTAINOverweight
Nov 5, 2026Baird
MAINTAIN
MAINTAINOutperform
Nov 4, 2026Needham
MAINTAIN
MAINTAINBuy
Oct 7, 2026Barclays
INITIATE
INITIATEOverweight
Sep 2, 2026Piper Sandler
REITERATE
REITERATEOverweight
Aug 5, 2026Needham
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$1.3M
sold · 4 insiders
DateInsiderTypeValue
Nov 12, 2026
Shvartsburg Alex
Chief Financial Officer
Nov 12, 2026
SELL$227.3K
Sep 15, 2026
Liddy Anne M.
Chief Legal Officer
Sep 15, 2026
AWARD6,291 sh
Sep 10, 2026
Bianchi Francesco
Director
Sep 10, 2026
SELL$273.0K
Sep 4, 2026
Story Brooke
Director
Sep 4, 2026
SELL$187.3K
Aug 31, 2026
Bianchi Francesco
Director
Aug 31, 2026
SELL$131.5K
Aug 11, 2026
Tezel Ahmet
Chief Innovation Officer
Aug 11, 2026
TO ISSUER$668.7K
Aug 11, 2026
Tezel Ahmet
Chief Innovation Officer
Aug 11, 2026
EXERCISE$668.6K
Aug 11, 2026
Tezel Ahmet
Chief Innovation Officer
Aug 11, 2026
TAX W/H$111.2K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q$1.06$0.99–$1.13-0.9%$386.5M
Current FY$4.43$4.40–$4.46+1.8%$1.5B
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
6,362,366
shares short
+2.6%
vs prior settlement
12.4
days to cover
≈11.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Alex Shvartsburg, an officer of LivaNova PLC, filed a Form 144 notice of intent to sell 2,500 shares of common stock…
144 · Impact 2/10
Nov 12, 2026 Insider
Shvartsburg Alex sold 2,500 shares
Chief Financial Officer @ $90.91 ($227.3K)
Nov 10, 2026 SEC
Invesco Ltd. filed a Schedule 13G disclosing a 5.3% passive stake in LivaNova PLC as of September 30, 2026…
SC 13G · Impact 3/10
Nov 5, 2026 SEC
FMR LLC (Fidelity) filed an amended Schedule 13G reporting a 7.1% passive stake in LivaNova as of September 30, 2026…
SC 13G/A · Impact 2/10
Nov 4, 2026 Earnings result
LIVN Q3 2026 Earnings: EPS $1.23 (+14.1% vs est)
Sep 30, 2026 Inst.
FMR LLC · ADD
3,976,650 shares ($304.2M)
Sep 30, 2026 Inst.
Invesco Ltd. · ADD
2,914,016 shares ($222.9M)
Sep 15, 2026 Insider
Liddy Anne M. was granted 6,291 shares
Chief Legal Officer
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 4, 2026
Earnings result
LIVN Q3 2026 Earnings: EPS $1.23 (+14.1% vs est)
Aug 5, 2026
Earnings date
LIVN Q2 2026 Earnings Before Market Open, 2026-08-05
May 13, 2026
Short interest
FTD: LIVN, 19,305 shares ($1.4M) failed to deliver
Settlement: 20260513, Price: $71.75, FTD Value: $1,385,133.75, LIVANOVA PLC SHS (GBR)
May 6, 2026
Short interest
FTD: LIVN, 18,361 shares ($1.1M) failed to deliver
Settlement: 20260506, Price: $57.59, FTD Value: $1,057,409.99, LIVANOVA PLC SHS (GBR)
May 6, 2026
Earnings date
LIVN Q1 2026 Earnings Before Market Open, 2026-05-06

SecBot reports

10 filings · 4 bullish · 0 bearish · 6 neutral
All LIVN filing & press-release reports (10)